BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 153 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,985 | -30.9% | 1,954 | +10.5% | 0.00% | -50.0% |
| Q2 2023 | $39,073 | +1.6% | 1,768 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $38,454 | +2.7% | 1,768 | -14.0% | 0.00% | 0.0% |
| Q4 2022 | $37,437 | -20.0% | 2,057 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $46,797 | +64.7% | 2,057 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $28,407 | +68.0% | 2,057 | +176.5% | 0.00% | 0.0% |
| Q1 2022 | $16,911 | -84.6% | 744 | -74.8% | 0.00% | 0.0% |
| Q4 2021 | $110,058 | -62.7% | 2,953 | -57.6% | 0.00% | -75.0% |
| Q3 2021 | $294,801 | -4.9% | 6,966 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $310,057 | +93.0% | 6,966 | +56.1% | 0.00% | +100.0% |
| Q1 2021 | $160,668 | -9.8% | 4,463 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $178,029 | +37.8% | 4,463 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $129,159 | – | 4,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |